Page last updated: 2024-08-24

topotecan and Atrophy

topotecan has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maidana, DE; Pellegrini, M; Shields, CL; Shields, JA1
Brennan, R; Kaste, SC; Orr, B; Tse, BC; Wilson, MW1

Other Studies

2 other study(ies) available for topotecan and Atrophy

ArticleYear
Choroidal thickness after intraarterial chemotherapy for retinoblastoma.
    Retina (Philadelphia, Pa.), 2014, Volume: 34, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Atrophy; Case-Control Studies; Child; Child, Preschool; Choroid; Female; Fluorescein Angiography; Humans; Infant; Infusions, Intra-Arterial; Male; Melphalan; Organ Size; Retinal Neoplasms; Retinoblastoma; Tomography, Optical Coherence; Topotecan

2014
Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma.
    Ophthalmology, 2015, Volume: 122, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Chemotherapy, Cancer, Regional Perfusion; Choroid; Choroid Diseases; Combined Modality Therapy; Diseases in Twins; Enophthalmos; Female; Fluorescein Angiography; Humans; Infant; Laser Coagulation; Magnetic Resonance Imaging; Melphalan; Ophthalmic Artery; Retinal Neoplasms; Retinoblastoma; Scleritis; Topoisomerase I Inhibitors; Topotecan; Twins, Monozygotic

2015